Trade Mark Journal No.2026/033 14 August 2026

WO0000001922856 (9,38,42,44)

Office of origin: United States of America

Date of International Registration:8 January 2026
Date of designation in the UK: 8 January 2026
Image for mark 1922856 PRE

International priority date claimed: 18 July 2025 (United States of America) (99291731)
Class 9
Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields.
Class 38
Telecommunications services; providing access to platforms related to health on the Internet; telecommunications services provided via internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data.
Class 42
Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields.
Class 44
Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

Verily Life Sciences LLC

Representative: Kilburn & Strode LLP, Lacon London, 84 Theobalds Road London WC1X 8NL UNITED KINGDOM